IRREVERSIBLE BLOCKADE OF CENTRAL 5-HT BINDING-SITES BY 8-METHOXY-2'-CHLORO-PAT

被引:23
作者
EMERIT, MB [1 ]
GOZLAN, H [1 ]
HALL, MD [1 ]
HAMON, M [1 ]
MARQUET, A [1 ]
机构
[1] COLL FRANCE,CHAIRE NEUROPHARMACOL,INSERM,U114,F-75231 PARIS 05,FRANCE
关键词
D O I
10.1016/0006-2952(85)90770-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:883 / 892
页数:10
相关论文
共 36 条
[1]   SYNTHESIS OF ALKOXY-1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES .I. 2-AMINO-, ALKYLAMINO-, AND DIALKYLAMINO-DERIVATIVES [J].
AMES, DE ;
EVANS, D ;
GREY, TF ;
ISLIP, PJ ;
RICHARDS, KE .
JOURNAL OF THE CHEMICAL SOCIETY, 1965, (APR) :2636-&
[2]   8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN, A NEW CENTRALLY ACTING 5-HYDROXYTRYPTAMINE RECEPTOR AGONIST [J].
ARVIDSSON, LE ;
HACKSELL, U ;
NILSSON, JLG ;
HJORTH, S ;
CARLSSON, A ;
LINDBERG, P ;
SANCHEZ, D ;
WIKSTROM, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (08) :921-923
[3]  
BENNETT JP, 1976, MOL PHARMACOL, V12, P373
[4]   PHOTOAFFINITY-LABELING OF SEROTONIN-BINDING PROTEINS [J].
CHENG, SH ;
SHIH, JC .
LIFE SCIENCES, 1979, 25 (26) :2197-2203
[5]   APORPHINES .50. KINETICS OF SOLVOLYSIS OF N-(2-CHLOROETHYL)NORAPOMORPHINE, AN IRREVERSIBLE DOPAMINE RECEPTOR ANTAGONIST [J].
COHEN, SA ;
NEUMEYER, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (10) :1348-1353
[6]  
CORTES R, 1984, British Journal of Pharmacology, V82, p202P
[7]  
DERMER O, 1969, ETHYLENIMINE OTHER A
[8]   ALTERATIONS IN CENTRAL NEUROTRANSMITTER RECEPTOR-BINDING SITES FOLLOWING ESTRADIOL IMPLANTATION IN FEMALE RATS [J].
GOETZ, C ;
BOURGOIN, S ;
CESSELIN, F ;
BRANDI, A ;
BRESSION, D ;
MARTINET, M ;
PEILLON, F ;
HAMON, M .
NEUROCHEMISTRY INTERNATIONAL, 1983, 5 (04) :375-383
[9]   IDENTIFICATION OF PRE-SYNAPTIC SEROTONIN AUTORECEPTORS USING A NEW LIGAND - H-3-PAT [J].
GOZLAN, H ;
ELMESTIKAWY, S ;
PICHAT, L ;
GLOWINSKI, J ;
HAMON, M .
NATURE, 1983, 305 (5930) :140-142
[10]   TURNOVER OF SPECIFIC [H-3]SPIPERONE AND [H-3]N,NORMAL-PROPYLNORAPOMORPHINE BINDING-SITES IN RAT STRIATUM FOLLOWING PHENOXYBENZAMINE ADMINISTRATION [J].
HALL, MD ;
JENNER, P ;
MARSDEN, CD .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (19) :2973-2977